220
Participants
Start Date
May 28, 2019
Primary Completion Date
March 15, 2024
Study Completion Date
March 15, 2024
Mayo Clinic in Rochester, Rochester
Lead Sponsor
National Institutes of Health (NIH)
NIH
National Cancer Institute (NCI)
NIH
Mayo Clinic
OTHER